D.J. St. Germain’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$93.2K Hold
177
﹤0.01% 390
2026
Q1
$99.5K Sell
177
-2
-1% -$1.28K ﹤0.01% 366
2025
Q4
$121K Sell
179
-253
-59% -$172K ﹤0.01% 377
2025
Q3
$276K Sell
432
-41
-9% -$24.9K 0.01% 277
2025
Q2
$254K Buy
473
+290
+158% +$139K 0.01% 275
2025
Q1
$76.9K Buy
183
+4
+2% +$1.74K ﹤0.01% 363
2024
Q4
$74K Buy
179
+150
+517% +$65.8K ﹤0.01% 376
2024
Q3
$14.7K Sell
29
-10
-26% -$4.86K ﹤0.01% 497
2024
Q2
$19K Buy
39
+12
+44% +$6.02K ﹤0.01% 484
2024
Q1
$14.6K Hold
27
﹤0.01% 517
2023
Q4
$15K Buy
+27
New +$12.7K ﹤0.01% 517

Other funds holding IDXX

D.J. St. Germain's IDXX Position: Q2 2026 in Review

D.J. St. Germain held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 177 shares worth $93.2K. The position accounts for ﹤0.01% of the portfolio, ranked #390.

D.J. St. Germain first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $276K in Q3 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • D.J. St. Germain held 177 shares of Idexx Laboratories worth $93.2K as of Q2 2026.
  • D.J. St. Germain left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of D.J. St. Germain's portfolio in Q2 2026, its #390 holding.
  • D.J. St. Germain first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • D.J. St. Germain's Idexx Laboratories position peaked at $276K in Q3 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.